Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6496
    -0.0004 (-0.07%)
     
  • OIL

    82.42
    -0.39 (-0.47%)
     
  • GOLD

    2,332.60
    -5.80 (-0.25%)
     
  • Bitcoin AUD

    97,604.80
    -4,055.61 (-3.99%)
     
  • CMC Crypto 200

    1,371.39
    -11.18 (-0.81%)
     
  • AUD/EUR

    0.6067
    -0.0003 (-0.05%)
     
  • AUD/NZD

    1.0956
    +0.0014 (+0.13%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,235.66
    -291.14 (-1.66%)
     
  • FTSE

    8,053.23
    +12.85 (+0.16%)
     
  • Dow Jones

    37,802.18
    -658.74 (-1.71%)
     
  • DAX

    17,849.21
    -239.49 (-1.32%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Is This Under-the-Radar COVID Stock the Next Moderna?

Is This Under-the-Radar COVID Stock the Next Moderna?

Gritstone Oncology (NASDAQ: GRTS) started the week as a little-known player in the coronavirus vaccine space. Its shares -- and market capitalization -- soared. Gritstone said its vaccine candidate targets that very problem.